Amwell (AMWL) IPO Opens 42% Higher

Today's IPO for Amwell (NYSE: AMWL) opened for trading at $25.51 after pricing 41,222,222 shares of its Class A common stock at an initial public offering price of $18.00 per share.

In addition, the underwriters have been granted a 30-day option to purchase up to 6,183,333 additional shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions, from Amwell and certain stockholders of Amwell . Amwell will not receive any proceeds from the sale of Class A common stock by the Selling Stockholders.

Morgan Stanley, Goldman Sachs & Co. LLC and Piper Sandler are acting as lead joint book-running managers for the offering. UBS Investment Bank, Credit Suisse, Cowen and Berenberg are acting as bookrunners for the offering.

Amwell is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 2,000 hospitals and 55 health plan partners with over 36,000 employers, covering over 80 million lives.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Singularity Future Technology closes $1.8M registered direct offering
• Suja Life refinances credit agreement, cuts borrowing spread